US 9403002
Swallowable capsule and method for stimulating incretin production within the intestinal tract
granted A61KA61K38/26A61P
Quick answer
US patent 9403002 (Swallowable capsule and method for stimulating incretin production within the intestinal tract) held by Rani Therapeutics, LLC expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/26, A61P, A61P3/04, A61P3/10